Cargando…

Robot-assisted sacral tumor resection: a preliminary study

BACKGROUND: Few studies have been done on robot-assisted sacral surgery. This study aims to evaluate the outcomes of seven patients with benign sacral or presacral tumors treated with a robotic surgical system at a single center. METHODS: All patients with benign sacral or presacral tumors who under...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Junqiang, Wu, Hui, Tu, Jian, Zou, Changye, Huang, Gang, Xie, Xianbiao, He, Yulong, Shen, Jingnan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5991456/
https://www.ncbi.nlm.nih.gov/pubmed/29875022
http://dx.doi.org/10.1186/s12891-018-2084-9
_version_ 1783329832695758848
author Yin, Junqiang
Wu, Hui
Tu, Jian
Zou, Changye
Huang, Gang
Xie, Xianbiao
He, Yulong
Shen, Jingnan
author_facet Yin, Junqiang
Wu, Hui
Tu, Jian
Zou, Changye
Huang, Gang
Xie, Xianbiao
He, Yulong
Shen, Jingnan
author_sort Yin, Junqiang
collection PubMed
description BACKGROUND: Few studies have been done on robot-assisted sacral surgery. This study aims to evaluate the outcomes of seven patients with benign sacral or presacral tumors treated with a robotic surgical system at a single center. METHODS: All patients with benign sacral or presacral tumors who underwent transperitoneal resection (between June 2015 and June 2016) using the da Vinci Si HD robotic surgical system (Intuitive Surgical Inc.) were included in this retrospective study. RESULTS: Seven patients with a mean age of 43.8 years (range: 22- 62 years) were included in this study. The operation time ranged from 60 to 335 min. Five out of these seven patients with presacral tumor underwent complete tumor resection by the da Vinci robotic surgical system, with a median blood loss of 52 ml. The other patients underwent excision of the presacral tumor by the da Vinci robotic surgical system, followed by a posterior approach, with a median blood loss of 675 ml. The histological diagnosis was schwannoma of the sacral nerve in five cases (71.5%). The other two cases were chordoma and solitary fibroma of the sacrum, respectively. No perioperative or postoperative complications were encountered. The average hospitalization stay was 5.7 days. No recurrences were found at follow-up 24 to 31 months later. CONCLUSION: Robot-assisted minimally invasive sacral surgery can provide precise dissection of the tissue under a perfect view. It is a technically feasible procedure that is associated with minimal blood loss, fewer injuries and short hospitalization. It is particularly suitable for presacral benign tumors.
format Online
Article
Text
id pubmed-5991456
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-59914562018-06-21 Robot-assisted sacral tumor resection: a preliminary study Yin, Junqiang Wu, Hui Tu, Jian Zou, Changye Huang, Gang Xie, Xianbiao He, Yulong Shen, Jingnan BMC Musculoskelet Disord Research Article BACKGROUND: Few studies have been done on robot-assisted sacral surgery. This study aims to evaluate the outcomes of seven patients with benign sacral or presacral tumors treated with a robotic surgical system at a single center. METHODS: All patients with benign sacral or presacral tumors who underwent transperitoneal resection (between June 2015 and June 2016) using the da Vinci Si HD robotic surgical system (Intuitive Surgical Inc.) were included in this retrospective study. RESULTS: Seven patients with a mean age of 43.8 years (range: 22- 62 years) were included in this study. The operation time ranged from 60 to 335 min. Five out of these seven patients with presacral tumor underwent complete tumor resection by the da Vinci robotic surgical system, with a median blood loss of 52 ml. The other patients underwent excision of the presacral tumor by the da Vinci robotic surgical system, followed by a posterior approach, with a median blood loss of 675 ml. The histological diagnosis was schwannoma of the sacral nerve in five cases (71.5%). The other two cases were chordoma and solitary fibroma of the sacrum, respectively. No perioperative or postoperative complications were encountered. The average hospitalization stay was 5.7 days. No recurrences were found at follow-up 24 to 31 months later. CONCLUSION: Robot-assisted minimally invasive sacral surgery can provide precise dissection of the tissue under a perfect view. It is a technically feasible procedure that is associated with minimal blood loss, fewer injuries and short hospitalization. It is particularly suitable for presacral benign tumors. BioMed Central 2018-06-06 /pmc/articles/PMC5991456/ /pubmed/29875022 http://dx.doi.org/10.1186/s12891-018-2084-9 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Yin, Junqiang
Wu, Hui
Tu, Jian
Zou, Changye
Huang, Gang
Xie, Xianbiao
He, Yulong
Shen, Jingnan
Robot-assisted sacral tumor resection: a preliminary study
title Robot-assisted sacral tumor resection: a preliminary study
title_full Robot-assisted sacral tumor resection: a preliminary study
title_fullStr Robot-assisted sacral tumor resection: a preliminary study
title_full_unstemmed Robot-assisted sacral tumor resection: a preliminary study
title_short Robot-assisted sacral tumor resection: a preliminary study
title_sort robot-assisted sacral tumor resection: a preliminary study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5991456/
https://www.ncbi.nlm.nih.gov/pubmed/29875022
http://dx.doi.org/10.1186/s12891-018-2084-9
work_keys_str_mv AT yinjunqiang robotassistedsacraltumorresectionapreliminarystudy
AT wuhui robotassistedsacraltumorresectionapreliminarystudy
AT tujian robotassistedsacraltumorresectionapreliminarystudy
AT zouchangye robotassistedsacraltumorresectionapreliminarystudy
AT huanggang robotassistedsacraltumorresectionapreliminarystudy
AT xiexianbiao robotassistedsacraltumorresectionapreliminarystudy
AT heyulong robotassistedsacraltumorresectionapreliminarystudy
AT shenjingnan robotassistedsacraltumorresectionapreliminarystudy